Cancer-Associated Fibroblast Risk Model for Prediction of Colorectal Carcinoma Prognosis and Therapeutic Responses

Figure 6

Multidimensional validation for risk score. Comparison of the effect of immunotherapy between the high- and low-risk groups in GSE39582 (a) and TCGA-COAD (d) cohorts. Comparison of the TIDE level between the high-and low-risk groups in GSE39582 (b) and TCGA-COAD (e) cohorts. Receiver-operating characteristic curves of the risk score in forecasting treatment effects in GSE39582 (c) and TCGA-COAD (f) cohorts.

(a)

(b)

(c)

(d)

(e)

(f)